相关实验视频

Updated: Jul 8, 2025

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

iGenSig-Rx:基于基因组签名的整体白盒工具,用于使用多omics数据建模癌症治疗反应

Sanghoon Lee¹, Min Sun¹, Yiheng Hu¹

¹University of Pittsburgh.

Research square

|December 11, 2023

概括

一个新的白盒工具,iGenSig-Rx,使用基因组签名建模治疗反应. 这种可解释的方法通过分析多omics数据,提高了精密瘤学的患者选择.

科学领域:

基因组学就是基因组学.
计算生物学计算生物学
在瘤学瘤学.

背景情况:

多omics测序已经准备好临床整合,需要强大的全基因组建模患者分层.
目前的方法缺乏可解释性和跨数据集的适用性,阻碍了量身定制的治疗干预.

结论:

iGenSig-Rx为精密瘤学提供了一个透明和可解释的解决方案.
该方法有望促进合理的患者选择,以进行量身定制的干预.
这种类型的建模方法在大数据驱动的癌症研究中具有广泛的应用.

更多相关视频

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...